Clinical trial
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
NCT00273247 · National Cancer Institute, Milan, Other · Completed
Key facts
| NCT number | NCT00273247 |
|---|---|
| Title | Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis |
| Official title | Adjuvant α-Interferon Treatment After Resection of Hepatocellular Carcinoma in HCV-Related Cirrhosis: a Randomized Trial on Prevention of Cancer Recurrence |
| Lead sponsor | National Cancer Institute, Milan, Other |
| Collaborators | Associazione Italiana per la Ricerca sul Cancro |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma, Hepatitis C Virus Infection, Liver Cirrhosis, Interferon Treatment, Hepatic Resection |
| Intervention type | Drug |
| Interventions | Interferon alpha-2b |
| Enrollment | 150 |
| Start date | Jun 1, 1998 |
| Completion | Sep 1, 2005 |
| First posted | Jan 9, 2006 |
| Last update posted | Jan 9, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: